The Emerging Role of Leptin Antagonist as Potential Therapeutic Option for Inflammatory Bowel Disease

International Reviews of Immunology - United Kingdom
doi 10.3109/08830185.2013.809071
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

The Emerging Role of miRNAs in Inflammatory Bowel Disease: A Review

Therapeutic Advances in Gastroenterology
Gastroenterology
2014English

Making Therapeutic Decisions in Inflammatory Bowel Disease: The Role of Patients

Current Opinion in Gastroenterology
Gastroenterology
2009English

Therapeutic Drug Monitoring in Inflammatory Bowel Disease

Gastroenterology
HepatologyGastroenterology
2017English

Endoscopic Therapeutic Approach for Dysplasia in Inflammatory Bowel Disease

Clinical Endoscopy
MedicineNuclear MedicineRadiologyImagingGastroenterology
2017English

Molecular Simulation of Oncostatin M and Receptor (OSM–OSMR) Interaction as a Potential Therapeutic Target for Inflammatory Bowel Disease

Frontiers in Molecular Biosciences
BiochemistryGeneticsMolecular Biology
2020English

Novel Therapeutic Targets in Inflammatory Bowel Disease

Prescriber
Pharmacology
2019English

Urinary Trypsin Inhibitor as a Therapeutic Option for Inflammatory Disorders

OA Biotechnology
2013English

The Role of Cytokines in Inflammatory Bowel Disease

Mediators of Inflammation
ImmunologyCell Biology
1994English

Role of Nutrition in Inflammatory Bowel Disease (IBD): New Therapeutic Approaches and Recent Outcomes

Journal of Nutritional Therapeutics
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy